title: GM-CSF and ganciclovir for cytomegalovirus infection after autologous bone-marrow transplantation.
authors.forename: L
authors.initials: L
authors.lastname: Fouillard
authors.forename: N C
authors.initials: NC
authors.lastname: Gorin
authors.forename: J P
authors.initials: JP
authors.lastname: Laporte
authors.forename: I
authors.initials: I
authors.lastname: Eugene-Jolchine
authors.forename: F
authors.initials: F
authors.lastname: Isnard
authors.forename: A
authors.initials: A
authors.lastname: Najman
mesh_terms: D016026:Bone Marrow Transplantation; D003115:Colony-Stimulating Factors / Q000008:administration & dosage*; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000209:etiology; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D015774:Ganciclovir / Q000008:administration & dosage*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000008:administration & dosage*; D006801:Humans
chemical_list: D003115:Colony-Stimulating Factors; D006133:Growth Substances; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D015774:Ganciclovir